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Mitochondrial calcium is an important modulator of
cellular metabolism. CCDC90A was reported to be
a regulator of the mitochondrial calcium uniporter
(MCU) complex, a selective channel that controls
mitochondrial calcium uptake, and hence was re-
named MCUR1. Here we show that suppression of
CCDC90A in human fibroblasts produces a specific
cytochrome c oxidase (COX) assembly defect, re-
sulting in decreased mitochondrial membrane po-
tential and reduced mitochondrial calcium uptake
capacity. Fibroblasts from patients with COX assem-
bly defects due to mutations in TACO1 or COX10
also showed reduced mitochondrial membrane po-
tential and impaired calcium uptake capacity, both
of which were rescued by expression of the respec-
tive wild-type cDNAs. Deletion of fmp32, a homolog
ofCCDC90A inSaccharomyces cerevisiae, an organ-
ism that lacks an MCU, also produces a COX defi-
ciency, demonstrating that the function of CCDC90A
is evolutionarily conserved. We conclude that
CCDC90A plays a role in COX assembly and does
not directly regulate MCU.
INTRODUCTION
The oxidative phosphorylation (OXPHOS) system is composed
of four respiratory chain enzyme complexes (I–IV) and the ATP
synthase (complex V). Complexes I, III, and IV work in concert
to pump protons from the mitochondrial matrix to the intermem-
brane space, forming the electrochemical gradient required for
ATP synthesis by complex V. Complex IV or cytochrome c oxi-
dase (COX) is composed of 14 subunits, three of which (COXI–
COXIII) form the catalytic core of the enzyme and are encoded
by themitochondrial genome (mtDNA). Many accessory proteins
are required to orchestrate the assembly of the COX complex
in the inner membrane (Soto et al., 2012), but the molecular
machinery necessary for the synthesis of the core subunits ofCellCOX on mitochondrial ribosomes is not well understood. We
previously identified the only known mammalian mitochondrial
translational activator protein, a coiled-coil domain protein
(CDDC44, renamed TACO1) which is required for the synthesis
of full-length COXI (Weraarpachai et al., 2009), prompting us to
investigate the function of another uncharacterized mitochon-
drial coiled-coil-containing protein, CCDC90A, in the biogenesis
of the COX complex.
CCDC90A was recently described as a regulator of the mito-
chondrial calcium uniporter (MCU), a highly selective channel
for the transport of Ca2+ across the inner mitochondrial mem-
brane (Baughman et al., 2011; De Stefani et al., 2011), and hence
was renamed MCUR1 (Mitochondrial Calcium Uniporter Regu-
lator1) (Mallilankaraman et al., 2012). Suppression of CCDC90A
in human cell lines resulted in decreased mitochondrial Ca2+ up-
take and a defect in mitochondrial respiration, whose molecular
basis was not determined (Mallilankaraman et al., 2012). MCU
forms a complex with several regulatory proteins, and the mito-
chondrial membrane potential drives Ca2+ movement through
the MCU channel (Sancak et al., 2013). Respiratory chain de-
fects invariably influence mitochondrial membrane potential;
however, few studies have investigated their direct conse-
quences on mitochondrial calcium uptake (Brini et al., 1999).
Here we show that CCDC90A primarily functions as a COX as-
sembly factor, suggesting that the mitochondrial calcium uptake
defect that was ascribed tomodulation of MCU function is in fact
secondary to the mitochondrial membrane depolarization
caused by the respiratory chain defect.
RESULTS
CCDC90A Knockdown Results in a COX
Assembly Defect
Human CCDC90A is a 39 kDa protein, with two predicted trans-
membranedomains, that localizes to the innermembraneofmito-
chondria (Mallilankaraman et al., 2012). However, alkaline
carbonate extraction on isolated mitochondria showed that while
CCDC90A was mainly found associated with the membrane
pellet, a fractionof theproteinwasconsistently found in the super-
natant, suggesting that it might exist in two different functional
pools, or transiently interact with the mitochondrial membrane
(Figure 1A). To investigate its function, we used siRNA-mediatedMetabolism 21, 109–116, January 6, 2015 ª2015 Elsevier Inc. 109
Figure 1. CCDC90A Depletion Produces a
COX Assembly Defect
(A) Alkaline carbonate extraction of human fibro-
blasts mitochondria showing that CCDC90A
appears in both the soluble and membrane bound
fractions. The membrane-bound COXI, and
membrane-associated SDHA, were used as
controls.
(B) siRNA-mediated knockdown of CCDC90A.
SDS-PAGE analysis showing the decrease of
CCDC90A levels in human fibroblasts with two
different siRNAs (90Asi1 and 90Asi2) compared to
a non-targeted siRNA (NTsi). Actin and SDHAwere
used as loading controls.
(C) BN-PAGE analysis of CCDC90A and MCU
silenced fibroblasts using subunit-specific anti-
bodies for the five OXPHOS complexes (Co I–Co
V) showing a specific decrease in COX (Co IV)
assembly in 90Ash cell lines (left panel) but no
change in the MCUsi cells (right panel). COX ac-
tivity was assessed by spectrophotometry,
normalized to citrate synthase activity, and ex-
pressed as percent of control.
(D) SDS-PAGE analysis showing COXI and COXII
steady-state levels in CCDC90A siRNA, shRNA
fibroblasts, fibroblasts from TACO1and COX10
patients, and in fibroblasts rescued by retroviral
expression of the respective wild-type cDNAs.suppressionofCCDC90A in immortalizedhumanfibroblasts. Two
different siRNAconstructs decreased the steady-state level of the
protein by90% (90Asi1) or80% (90Asi2) (Figure 1B). We also
generated a series of stable clonal cell lines in which CCDC90A
was silenced by lentiviral-mediated shRNA. Analysis of the
OXPHOS complexes by BN-PAGE showed that suppression of
CCDC90A resulted in a specific defect in COX assembly, while
the assembly of the other complexes was indistinguishable from
control (Figure 1C and see Figure S1A available online). Different
shRNA clones showed a graded decrease of COX assembly
that correlatedwith decreasedCOXactivity, andwith the residual
level of CCDC90A (Figure 1C). Clone 1 (Cl.1) was kept for analysis
and is further referenced as 90Ash. Silencing MCU had no effect
on the assembly of the OXPHOS complexes (Figure 1C).110 Cell Metabolism 21, 109–116, January 6, 2015 ª2015 Elsevier Inc.Wenext assessed the levels of the COX
subunits by SDS-PAGE. Both siRNA- and
shRNA-mediated knockdowns resulted
in reduced steady-state levels of COXI
and COXII, a pattern that is invariably
observed in the context of a COX assem-
bly defect, (Figure 1D), while the steady-
state levels of subunits of the other
OXPHOS complexes were unaffected
(Figure S1B). As positive controls, we
used two fibroblast lines from patients
with mutations in TACO1 (Weraarpachai
et al., 2009), which is required for the syn-
thesis of full-length COXI, or COX10,
which is required for the synthesis of
heme a, a prosthetic factor in the catalytic
core of COX (Antonicka et al., 2003).
Fibroblasts from both patients had an iso-lated COX assembly defect that was rescued by retroviral-medi-
ated expression of the wild-type cDNA (Figure 1D).
To test whether the COX assembly defect observed resulted
from a mitochondrial translation defect, we pulse-labeled the
mitochondrial translation products with [35S]methionine/cysteine
in the presence of anisomycin, a reversible inhibitor of cytosolic
translation, in the 90Ash cell line treated for an additional
3 days with 90Asi1 to insure maximal knockdown of the protein
(90Akd). We then chased the label and sampled at seven
different time points over a time course of 17.5 hr to investigate
the stability of the individual polypeptides. There were no signif-
icant differences in the rates of synthesis of the mtDNA encoded
COX subunits (Figure 2A, lane 0.2 hr); however, there were
marked differences in their turnover (Figure 2B, left panels). While
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Figure 2. Rapid Turnover of Newly Synthe-
sized COXII in CCDC90A-Depleted Cells
(A) SDS-PAGE analysis of a pulse/chase experi-
ment in which the mtDNA-encoded polypeptides
were labeled with [35S]methionine/cysteine in
control and 90Akd cells. Mitochondrial translation
products were pulse-labeled for 1h and chased for
0.2h to 17.5h.
(B) Turnover of newly synthesized mitochondrial
polypeptides. Labeling intensities of COX I, II, III,
ND1 (CoI), Cytb (CoIII) and ATP8/ND4L for control
and 90Akd cells were quantified and normalized to
ATP6 (CoV). Results are expressed as a percent-
age of initial counts (lane 0.2h)time course of the decay of newly synthesized COXI in the 90Akd
cells was similar to control, COXI levels were about 2-fold lower
at the end of the 17.5 hr chase. Strikingly, COXII was turned over
at amuch faster rate in 90Akd cells, leading to a 5% residual level
after 17.5 hr as compared to 40% in control. In contrast, the rate
of COXIII turnover in 90Akd cells was decreased compared toCell Metabolism 21, 109–11control. The turnover of newly synthe-
sized subunits of other OXPHOS com-
plexes showed similar profiles as shown
for cytb, ATP8/ND4L, andND1 (Figure 2B,
right panels). COXI is the first subunit to
enter the assembly pathway, COXII, then
COXIII being incorporated in the complex
after the formation of a subassembly
comprising COXI, COX4, and COX5a
(Stiburek et al., 2005). The early instability
of newly synthesized COXII subunit
compared to the other COX subunits sug-
gests that CCDC90A might function in
chaperoningCOXII into an early COX sub-
complex or play a role in the addition of
the prosthetic factors that are necessary
to stabilize an assembly intermediate.
Second-dimension BN-PAGE analysis in
a control cell line showed that CCDC90A
did not comigrate with fully assembled
or subcomplexes of complex IV, but
rather ran at its apparent monomeric mo-
lecular weight (Figure S1C). Together
these results suggest that CCDC90A
plays a role in the early steps of COX as-
sembly, likely involving incorporation or
maturation of COXII.
Fibroblasts Defective in COX
Assembly Have Impaired
Mitochondrial Calcium Uptake
Mallilankaraman et al. (Mallilankaraman
et al., 2012) described an impairment of
mitochondrial Ca2+ uptake in cells lacking
CCDC90A by investigating the response
to different stimuli. Thapsigargin and his-
tamine both trigger an elevation of cyto-
solic [Ca2+] and enhance mitochondrialCa2+ uptake. We first used thapsigargin, which specifically in-
hibits SERCA (the sarco/endoplasmic reticulum Ca2+-ATPase),
which is responsible for Ca2+ ERpumping, and assessed the rela-
tive mitochondrial calcium response by monitoring the change in
fluorescence intensity of the Ca2+ binding cytosolic probe Fluo-
forte. Typical thapsigargin responses are shown for all cell lines6, January 6, 2015 ª2015 Elsevier Inc. 111
(legend on next page)
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that we investigated (Figures S2A and S2B). Fibroblasts in which
CCDC90A was silenced by shRNA or siRNA had 40% of the
Ca2+ uptake activity of controls, confirming previous observations
(Mallilankaraman et al., 2012) (Figure 3A). To determine if a COX
assembly defect could account for such a phenotype, we
measured relative mitochondria Ca2+ uptake in fibroblasts from
both TACO1 andCOX10 patients and found a similar Ca2+ pump-
ing deficiency (63%–65%) compared to cells in which the genetic
defects were rescued by expressing wild-type cDNAs. Calcium
fluxes across the plasma membrane also contribute to cellular
calcium homeostasis, and the above experiments do not exclude
a role for plasmamembrane calcium transporters in the clearance
of cytosolic calcium after thapsigargin treatment. To address this
issue, we directly measured maximal mitochondrial calcium up-
take capacity following histamine stimulation by monitoring
the change in fluorescence of a mitochondrial Rhod2-AM probe,
a method that has been validated in several previous studies
(Collins et al., 2001; Mallilankaraman et al., 2012; Paillard et al.,
2013; Scorrano et al., 2003). This produced similar results: 41%
of Ca2+ uptake activity in 90Ash compared to control, and 63%
and 59% in TACO1- and COX10-deficient cells, respectively,
compared to cells rescued with the wild-type cDNA (Figure 3B).
Thus, even if plasma membrane calcium extrusion plays a role
in calcium clearance, our results strongly suggest that the rates
of calciumextrusion are not significantly different between control
cells and cells with COX assembly defects.
To further evaluate the relevance of these results, we assessed
the thapsigargin response in r0 cells that we generated froma hu-
man 143B osteosarcoma cell line. The absence of mitochondrial
DNA in r0 cells completely abrogates assembly of a functional
OXPHOS system leading to a drastic reduction of mitochondrial
membrane potential. Consistent with this, r0 cells showed a
92% deficiency in mitochondrial Ca2+ uptake compared to con-
trol (Figure S2B). TheCa2+ uptake deficiencywas not due to alter-
ations in the levels of MCU or its partner MICU1 in any of the cell
lines we investigated (Figures S3A and S3B).
Mallilankaraman et al. (Mallilankaraman et al., 2012) reported
that silencing of CCDC90A resulted in a deficiency of mitochon-
drial respiration, but they did not characterize the molecular
defect. It has long been known that mitochondrial Ca2+ is
required to maintain the full activity of Krebs cycle enzymes in
themitochondrial matrix (Wan et al., 1989). Pyruvate dehydroge-
nase (PDH) is the key enzyme catalyzing the first step of the
Krebs cycle, and is one of the most sensitive enzymes to matrix
[Ca2+]. Its activity is controlled by a Ca2+-dependent phospha-
tase (PDPC1) that maintains the enzyme in a nonphosphorylatedFigure 3. DecreasedMitochondrial Ca2+ Uptake Correlates with the Los
blasts and COX-Deficient Patient Fibroblasts
(A; left panels) Representative Ca2+ response of cells loadedwith the intracellular C
F0 decrease represents the linear fit of the relative mitochondrial uptake measure
Figure S2). (A; right panels) Histograms representing the relative mitochondrial Ca
independent experiments ; mean ± SEM.
(B ; left panels) Representative Ca2+ response of cells loadedwith themitochondria
arrow). Mitochondrial calcium uptake was assessed by analysis of the maxim
Histograms representing the relative mitochondrial Ca2+ uptake normalized to
experiments; n = 3 independent experiments.
(C) Live cells were incubated with 200nMTMRE andMtDRFM for 20min and signa
of fluorescence ratio TMRE/MtDRFM per cell ratio to control/rescue (lower panels
bar=10 mm.
Cellstate for maximal activity (Denton et al., 1972). Knockout of the
ER InsP(3) receptor prevents constitutive calcium entry into the
mitochondria, and results in a marked increase in the P-PDH/
PDH ratio (Ca´rdenas et al., 2010). Therefore, there is a wide-
spread belief that disturbing calcium entry via the MCU pathway
should affect mitochondrial metabolism. However, recent publi-
cations show that reducing the levels of MCU (Baughman et al.,
2011), or its partner MICU1 (Perocchi et al., 2010), does not
markedly affect mitochondrial respiration in human cell lines.
However, a muscle-restricted effect on PDH phosphorylation
was observed in an MCU germline knockout mouse (Pan et al.,
2013). This suggests that even in the absence of MCU, there is
still enough Ca2+ entry into mitochondria to ensure the full activ-
ity of Krebs cycle enzymes in most cells. Nevertheless, we as-
sessed the levels of P-PDH/PDH by immunoblot analysis in
CCDC90A silenced cells. The results showed no increase of P-
PDH in either CCDC90A siRNA- or shRNA-mediated suppres-
sion compared to control (Figure S3B). Together, these results
suggest that the respiration deficiency Mallilankaraman et al.
(Mallilankaraman et al., 2012) observed was not due to Ca2+ defi-
ciency, but rather a consequence of the COX assembly defect.
Mitochondrial Calcium Uptake Deficiency Correlates
with the Mitochondrial Membrane Potential Defect
Contact sites between mitochondria and the endoplasmic retic-
ulum favor mitochondria Ca2+ delivery at specific sites of locally
high Ca2+ concentrations (Rizzuto et al., 1998). MCU is a voltage-
gated ion channel; thus, mitochondrial Ca2+ pumping efficiency
relies on mitochondrial membrane potential, and the defects we
observed in Ca2+ uptake should reflect changes in mitochondrial
membrane potential. Tetramethylrhodamine, ethyl ester (TMRE)
is a cell-permeant, positively charged dye that readily accumu-
lates in active mitochondria due to the net negative charge
across the mitochondrial inner membrane. MitoTracker Deep
Red FM (MtDRFM) can label active or inactive mitochondria,
as its accumulation does not depend on mitochondrial mem-
brane potential. We therefore compared TMRE/MtDRFM accu-
mulation in live cells to assess the mitochondrial membrane
potential in our cell lines. CCDC90A-defective cell lines 90Ash,
90Asi1, and 90Asi2 showed a consistent 60%–65% reduction
in the TMRE/MtDRFM ratio compared to control (Figures 3C
and S3C), whereas no significant difference could be detected
in cells in which MCU was silenced (Figure 3C, left panels).
TACO1- and COX10-defective cells showed a 40% decrease
in this ratio compared to their rescued counterparts (Figure 3C,
right panels), strikingly reflecting the mitochondrial calciums ofMitochondrial Membrane Potential in CCDC90A-Deficient Fibro-
a2+-sensitive dye FluoForte and stimulated with 10 mMof thapsigargin. TheDF/
d during a 30 s period after the maximum fluorescence was reached. (see also
2+ uptake normalized to control/rescue; 4 analyzed fields per experiment ; n = 3
l Ca2+-sensitive dye Rhod-2-AM and stimulated with 10 mMof histamine (green
al mitochondrial calcium peak (F/F0 Rhod-2 AM maximal). (B ; right panels)
control/rescue ; mean ± SEM, 10 cells per field were analyzed; 3 fields per
l was acquired successively at 565 nm and 640 nm (upper panels). Quantitation
) ; mean ± SEM, nR 50 analyzed cells from 3 independent experiments. Scale
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Figure 4. Deletion of fmp32, the Saccharo-
myces cerevisiaeCCDC90AHomolog, Results
in COX Deficiency
(A) Plate growth assay of control andDfmp32 cells on
media supplemented with glucose or glycerol.
(B) Mitochondria stained with MitoGFP show frag-
mentation of the mitochondrial network in Dfmp32
cells.
(C) Absorption spectra of cytochromes c, b, and
a+a3 of control (red) and Dfmp32 cells (black).
Histograms show quantification of Cyt a+a3/Cyt c
and Cyt b normalized to control.
(D) Ratio of COX/SCCR activity in control and
Dfmp32 cells.uptake defect we observed above. We conclude that an isolated
COX deficiency reduces mitochondrial membrane potential, and
that the severity of this phenotype determines the degree of
impairment of mitochondrial Ca2+ uptake. On the other hand,
silencing MCU does not affect the assembly of any OXPHOS
complex, nor does it impair mitochondrial membrane potential,
confirming previous observations and ruling out an effect of
mitochondrial calcium homeostasis on COX assembly.
Deletion of fmp32, the Homolog of CCDC90A in Budding
Yeast, Results in a COX Deficiency
Homologs of MCU have been reported in a large number of eu-
karyotes, includingmany fungi, but not in any of 22 analyzed yeast
species (Bick et al., 2012). CCDC90A has a predicted homolog in
Saccharomyces cerevisiae, namely fmp32 (Pendin et al., 2014).
As Saccharomyces lacks amitochondrial Ca2+ uniporter, it seems114 Cell Metabolism 21, 109–116, January 6, 2015 ª2015 Elsevier Inc.likely that fmp32p has a function unrelated
to mitochondrial Ca2+ uptake. Fmp32p is
significantly shorter than its human homolog
(207 versus 359 amino acids), lacking the
N-terminal part of the human protein, but
exhibiting strong sequence homology from
residues 137–359 of the human protein (Fig-
ure S4). We therefore investigated COX
assembly in a Dfmp32 strain. The Dfmp32
strain showed normal growth in glucose-
supplemented media at 28C or 36C (Fig-
ure 4A, left panel); however, when grown
on a nonfermentable carbon source (glyc-
erol) (Figure 4A, right panel), there was a
growth defect that was markedly increased
at 36C, indicating reduced OXPHOS func-
tion. MitoGFP labeling showed extensive
mitochondrial network fragmentation at
both temperatures (Figure 4B). To further
investigate the basis for this growth pheno-
type, we assessed the steady-state levels of
the mitochondrial cytochromes. In yeast as
in mammals, cytochrome a+a3 is incorpo-
rated into COXI, forming part of the catalytic
core of the enzyme. It is therefore essential
for COX activity. Quantification of the cyto-
chrome spectra showed that the ratio Cyt
a+a3/Cyt c decreased by 46% in theDfmp32 strain compared to control, while cytochrome b, the
complex III prosthetic group, was unchanged (Figure 4C). Finally,
we showed that the Dfmp32 strain exhibited a temperature-
dependent defect of COX activity, as the ratio COX/SCCR (succi-
nyl CoA reductase) was decreased by 20%and 35%at 28C and
36C, respectively, compared to control (Figure 4D). From these
results we conclude that fmp32p is necessary for the stability of
the catalytic core of COX in yeast.
DISCUSSION
This study demonstrates that loss of CCDC90A function results
in a specific defect in the assembly of COX, leading to a reduc-
tion in mitochondrial membrane potential and impaired mito-
chondrial Ca2+ uptake capacity. Analysis of a series of clones
in which CCDC90A was depleted by shRNA showed that the
COX assembly defect was proportional to the residual level of
CCDC90A. Further, cells with COX assembly defects due to
genetically defined mutations in other COX assembly factors ex-
hibited a similar phenotype, which was rescued by expression
of the appropriate wild-type cDNAs. Thus, it does not seem
necessary to postulate that CCDC90A has a direct effect on
the MCU complex in order to account for the calcium uptake
defect that occurs with loss of CCDC90A function. Consistent
with these observations, affinity purification of MCU recovered
four additional components of the core complex (MCUb,
MICU1, MICU2, and EMRE) that either regulate or are necessary
for channel activity, but failed to identify CCDC90A (Sancak
et al., 2013), further suggesting that CCDC90A has a role outside
the core complex. Further, although we were able to nearly
quantitatively immunopreciptate native MCU with the anti-
MCU antibody, we could not detect CCDC90A as a coimmuno-
precipitating protein by immunoblot analysis (data not shown).
Finally, our analysis of yeast strains deleted for the CCDC90A
homolog fmp32 showed a growth defect on a nonfermentable
carbon source, and a COX defect similar to that observed in hu-
man cells, demonstrating that the function of CCDC90A is evolu-
tionarily conserved. CCDC90A appears to be involved with early
COX assembly, and loss of function particularly affects the turn-
over of newly synthesized COXII, but its exact molecular function
remains to be determined.
Respiratory chain activity is dependent on the Krebs cycle,
which provides the NADH necessary for complex I activity, and
mitochondrial Ca2+ is essential for the full activity of some en-
zymes in the Krebs cycle. On another hand, the activity of the
MCU is voltage dependent and thus relies on a functional respi-
ratory chain to maintain a normal proton electrochemical
gradient across the inner mitochondrial membrane. The isolated
COX deficiencies that we studied reduce the mitochondrial
membrane potential and impair Ca2+ uptake activity provoked
by addition of thapsigargin or histamine. However, at physiolog-
ical [Ca2+], this deficiency may not in fact have a major impact on
mitochondrial Ca2+ homeostasis, as evidenced by the fact that
P-PDH levels in the respiratory chain-deficient cells were un-
changed. This study demonstrates that a prerequisite for assign-
ing a specific role to a protein in the regulation of Ca2+ uptake is
to establish the integrity of the OXPHOS system. Although we
cannot completely exclude a role for CCDC90A in mitochondrial
calcium dynamics, or that different pools may have more than
one functional role, our results suggest that CCDC90A is not
directly implicated in MCU function, and that the Ca2+ uptake
defect associated with loss of CCDC90A function is likely sec-
ondary to the respiratory chain deficiency.EXPERIMENTAL PROCEDURES
Human Studies
The research studies on patient cell lines were approved by the institutional re-
view board of the Montreal Neurological Institute, McGill University.
Knockdown Strategies
Two Stealth RNA interference duplex constructs directed against human
CCDC90A (http://rnaidesigner.lifetechnologies.com/rnaiexpress) were trans-
fected according to the manufacturer’s specifications (Invitrogen). CCDC90A
stable knockdown cell lines were made using the lentiviral vector (pLKO.1)
containing a specific small hairpin sequence directed against CCDC90ACell(see Supplemental Information for more details). Fibroblasts were transduced
with viral supernatant as described elsewhere (Antonicka et al., 2010).
Mitochondrial Isolation and Localization Experiments
Cells were resuspended in ice-cold 250 mM sucrose/10 mM Tris-HCl/1 mM
EDTA (pH 7.4) and homogenized with seven passes in a prechilled, zero clear-
ance homogenizer (Kimble/Kontes, Vineland, NJ). A postnuclear supernatant
was obtained after centrifugation of the samples twice for 10 min at 600 g.
Mitochondria were pelleted at 10,000 g and washed once in the same buffer.
For submitochondrial localization experiments, mitochondria were further ex-
tracted with 100 mM alkaline carbonate at pH 11.5 as previously described
(Weraarpachai et al., 2009), and the relevant fractions were analyzed by
SDS-PAGE.
Enzyme Assays
A spectrophotometric assay of whole-cell extracts from control and shRNA-
treated cells was used to measure the enzymatic activity of COX in fibroblasts
as described previously (Antonicka et al., 2003).
Native, Denaturing, and Two-Dimensional PAGE
Blue native PAGE (BN-PAGE) was used to separate individual OXPHOS com-
plexes. Mitoplasts, prepared from fibroblasts by treatment with 0.8 mg of
digitonin per milligram of protein, were solubilized with 1% lauryl maltoside.
Samples (10–20 mg) were run on 6%–15% polyacrylamide gradient gels as
described in detail elsewhere (Leary, 2012). The following antibodies were
used in this study: anti-CCDC90A (LS-Bioscience and AVIVA), anti-SDHA,
a-actin, COX I, COX II, COX IV, PDH (Abcam), MCU (1/500 dilution), P-PDH
(Sigma), and MICU1 (1/500 dilution; Cell Signaling).
Radiotracer Labeling of Mitochondrial Translation Products
Cells were pretreated with chloramphenicol for 20 hr before labeling. Pulse-
chase labeling of mitochondrial translation products in control and siRNA-
treated fibroblasts was performed with 200 mCi/ml of a [35S]methionine/
cysteine mix (PerkinElmer) in DMEM lackingmethionine and cysteine and con-
taining 100 mg/ml of a cytoplasmic translation inhibitor anisomycin as
described in detail elsewhere (Sasarman and Shoubridge, 2012). Gels were
analyzed on a Phosphorimager (Amersham Biosciences), and the signals
were quantified using ImageQuant software.
Mitochondrial Calcium Measurements
Relative mitochondrial Ca2+ uptake was analyzed as described previously
(Prudent et al., 2013). Briefly, extramitochondrial free Ca2+ was monitored in
cells using the FluoForte probe (Enzo Life Sciences). Cells cultured on Nunc
Lab-Tek chambered cover glass were incubated with 5 mM FluoForte in a
Ca2+-free balanced salt solution (BSS) (121 mM NaCl, 5.4 mM KCl, 0.8 mM
MgCl2, 6 mM NaHCO3, 5.5 mM D-glucose, 25 mM HEPES [pH 7.3]) for 1 hr
at 37C. Fluorescence values were collected every 2.5 s using an Olympus
IX81 inverted microscope using Olympus FV1000 confocal scanning system
fitted with a 303 objective.
To measure maximal mitochondrial calcium uptake, cells were washed three
times and incubated with 2.5 mM Rhod2-AM (Molecular probes, Invitrogen) in
BSS containing 2 mM CaCl2 (121 mM NaCl, 5.4 mM KCl, 0.8 mM MgCl2,
6 mM NaHCO3, 2 mM CaCl2, 5.5 mM D-glucose, 25 mM HEPES [pH 7.3])
with 0.002% pluronic acid (SIGMA) for 15 min at 37C. Cells were then washed
three times andde-esterified inBBSbuffer for 30min atRT. Fluorescence values
were then collected every 2 s for 4 min using an Olympus inverted spinning disk
fitted with a 303 objective. After 20 s of measurement, 10 mM of histamine
(Sigma) in BBS was injected, and Rhod-2 fluorescence (u.a) was recorded.
Mitochondria Membrane Potential Measurements
TMRE and MtDRFM (Life Technologies) were incubated for 20 min in medium
and washed for 10 min at 37C. Images were acquired immediately with an
Olympus IX83, Ikogawa spinning disc system microscope coupled with a
Neo camera (Andor), and signal was quantified with ImageJ.
Yeast Cell Culture
Strains used in this study where derived from BY4741 (EUROSCARF collec-
tion). Yeasts were cultured at 28C or 36C in YPD (1% yeast extract, 1%Metabolism 21, 109–116, January 6, 2015 ª2015 Elsevier Inc. 115
bacto peptone, 2% glucose), YPGal (1% yeast extract, 1% bactopeptone, 2%
galactose), or YPG (1% yeast extract, 1% bactopeptone, 2% glycerol). All me-
dia were supplemented with 2% bacto agar for solid media.
Whole-Cell Cytochrome Spectra and Enzyme Activity Assays
The cells were transferred to a homemade cuvette of 1 mm width, and spectra
were then recorded at196C between 490 and 630 nm in a Cary 400 spectro-
photometer (Varian) after complete reduction of cytochromes by mixing 3–5 mg
of sodium dithionite with the cells (Claisse ML, 1970). Cytochrome c oxidase
(complex IV) and succinate cytochrome c oxidoreductase (complex II + complex
III)weremeasuredcombined in thesamecuvette asdescribed (Be´nit etal., 2006).
Statistical Analysis
All data are reported as means ± SEM. Statistical significance was determined
using unpaired t tests. Differences were accepted as significant at the 99.9%
level (p < 0.001).
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